By 2034, U.S. Antifungal Drugs Market Set to Achieve USD 7.96 Billion
Market Overview U.S. Antifungal Drugs Market size and share is currently valued at USD 5.98 billion in 2024 and is anticipated to generate an estimated revenue of USD 7.96 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 2.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034 The U.S. antifungal drugs market is witnessing steady expansion as the prevalence of fungal infections continues to rise across the country. With increasing awareness of fungal diseases, advances in drug formulations, and heightened healthcare access, the demand for antifungal therapies is growing significantly. Antifungal drugs are essential in the treatment of conditions caused by fungal pathogens, including yeast infections, aspergillosis, candidiasis, and dermatophytosis. The market encompasses prescription drugs, over-the-counter (OTC) medications, and hospital-administered therapies de...